PetMed Specific, Inc. Units Third Quarter 2022 Earnings Name

DELRAY BEACH, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) — PetMed Express, Inc. (PETS) (the “Firm”), Your Trusted Pet Well being Skilled™ will maintain a convention name on Monday, February 6, 2023 at 4:30pm Japanese time to debate its monetary outcomes for the third quarter ended December 31, 2022. Monetary outcomes might be issued in a press launch previous to the decision.

PetMed administration will host the convention name, adopted by a query and reply interval.

Date: Monday, February 6, 2023
Time: 4:30pm Japanese time (1:30pm Pacific time)
U.S. dial-in quantity: 877-407-0789
Worldwide quantity: 201-689-8562
Webcast: PetMeds Q3 Earnings Webcast

Please name the convention phone quantity 5-10 minutes previous to the beginning time. When you’ve got any issue connecting with the convention name, please contact MZ Group at 561-374-0177.

A telephonic replay of the convention name may even be out there after 7:30 PM Japanese time on the identical day via February 20, 2023.

Toll-free replay quantity: 844-512-2921
Worldwide replay quantity: 412-317-6671
Replay passcode: 13735907

About PetMed Specific

Based in 1996, PetMeds is Your Trusted Pet Well being Skilled™, delivering prescription and non-prescription pet medicines and different well being merchandise for canine, cats, and horses at aggressive costs direct to the patron via its 1-800-PetMeds toll free quantity and thru its web site at www.petmeds.com.

Ahead-Wanting Statements
This press launch might include “forward-looking” statements, as outlined within the Non-public Securities Litigation Reform Act of 1995 or by the Securities and Change Fee, that contain a lot of dangers and uncertainties, together with the Firm’s potential to fulfill the goals included in its marketing strategy. Vital elements that would trigger outcomes to vary materially from these indicated by such “forward-looking” statements are set forth in Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operations within the PetMed Specific Annual Report on Type 10-Ok for the yr ended March 31, 2022. The Firm’s future outcomes might also be impacted by different danger elements listed occasionally in its SEC filings, together with, however not restricted to, the Firm’s Type 10-Q and its Annual Report on Type 10-Ok.

Investor Contact:
MZ North America
Brian M. Prenoveau, CFA
[email protected]
(561) 374-0177